Evidence map›Paper›PMID 36387182›Full record

ArticleFrontiers in oncology2022

Emerging trends and focus of giant cell tumor of bone research from 2001-2021: A visualization research.

Ying-Song Han, Yi-Fan Yang, Gang Chen, Hai-Liang Yu, Zhi-Guo Zhang, Bin Zhou

Abstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Surgical and radiological outcomes of giant cell tumor of the bone: prognostic value of Campanacci grading and selective use of denosumab.Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology · 2025
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ying-Song HanDepartment of Spine Surgery, Xiangtan Central Hospital, Xiangtan, China.
Yi-Fan YangDepartment of Spine Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.
Gang ChenDepartment of Spine Surgery, Xiangtan Central Hospital, Xiangtan, China.
Hai-Liang YuDepartment of Spine Surgery, Xiangtan Central Hospital, Xiangtan, China.
Zhi-Guo ZhangDepartment of Spine Surgery, Xiangtan Central Hospital, Xiangtan, China.
Bin ZhouDepartment of Spine Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Giant cell tumor of bone is a highly invasive benign tumor with a high postoperative recurrence rate.

objectiveThis study aims to analyze the research hotspots and trends of global research on giant cell tumor of bone in the past 20 years, to provide a reference for relevant personnel in this field to carry out academic research.

methodsThe literature related to giant cell tumor of bone from 2001 to 2021 was retrieved from the Web of Science. The bibliometrics research method and VOS Viewer were used to extract and analyze the keywords of the journal authors' research institutions, and the research status and development direction in the recent 20 years were visualized.

resultsA total of 2063 articles were included. The number of global publications is increasing every year. The United States contributes the most to global research, with the most citations and the highest H-index. The journal

conclusionThe study of giant cell tumor of bone is a hot spot of continuous development and has an important contribution to human health.

Indexed as

bibliometricsgiant cell tumor of boneglobal trendresearch focusvisualized study

Identifiers

PMID36387182
PMCPMC9650254

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.